# TNRC6A

## Overview
TNRC6A, or trinucleotide repeat containing 6A, is a gene that encodes a protein belonging to the GW182 family, which is integral to RNA-mediated gene silencing. The TNRC6A protein functions as a scaffold that facilitates interactions between Argonaute proteins and the CCR4-NOT complex, playing a pivotal role in microRNA (miRNA)-mediated gene silencing and mRNA degradation (Munakata2021Identification; Nishi2012Human). It is characterized by several functional domains, including a central ubiquitin-associated domain and a C-terminal RNA recognition motif, which are essential for its interactions and regulatory functions (Chaston2017Structural). TNRC6A is involved in both nuclear and cytoplasmic RNA silencing processes, and its activity is modulated by phosphorylation and interactions with various proteins, such as GIGYF and TRIM65 (Li2014TRIM65; Sobti2023Molecular). Mutations in TNRC6A have been linked to certain cancers and neurological disorders, highlighting its clinical significance (Eriguchi2017Identification; Kim2010Somatic).

## Structure
The TNRC6A protein is part of the GW182 family and plays a crucial role in RNA-mediated gene silencing. Structurally, TNRC6A contains several domains, including a central ubiquitin-associated domain and a C-terminal RNA recognition motif (RRM), which are essential for its function in mRNA degradation and interaction with Argonaute proteins (Chaston2017Structural). The C-terminal region, known as the silencing domain, is vital for recruiting deadenylase complexes and inducing mRNA silencing (Chaston2017Structural).

The nuclear localization signal (cNLS) of TNRC6A, specifically residues 1179-1187, is a conserved sequence crucial for its nuclear localization. This cNLS binds to importin-alpha (Impα) in an extended conformation, with basic side chains interacting with the binding pockets of Impα. The critical P2 lysine forms a salt bridge with Asp192 of mImpα1, which is essential for binding (Chaston2017Structural). The interaction between TNRC6A and Impα is conserved between mouse and human proteins, highlighting the evolutionary conservation of this mechanism (Chaston2017Structural).

TNRC6A also contains a conserved PPGL motif within its silencing domain, which is important for translational repression. This motif interacts with the GYF domains of GIGYF proteins, forming a hydrophobic PRS-binding groove that is crucial for the specificity of 4EHP-mediated translational repression (Sobti2023Molecular). The interaction with GIGYF proteins is essential for TNRC6A's function in translational regulation (Sobti2023Molecular).

## Function
TNRC6A, a member of the GW182 protein family, plays a crucial role in microRNA (miRNA)-mediated gene silencing. It functions as a scaffold protein that connects Argonaute (Ago) proteins to the CCR4-NOT complex, facilitating RNA silencing and mRNA degradation. TNRC6A interacts with Ago proteins through GW-repeated Ago-binding motifs, which are essential for its role in gene silencing (Munakata2021Identification; Nishi2012Human). 

TNRC6A is a nuclear-cytoplasmic shuttling protein, regulated by nuclear localization signals (NLS) and nuclear export signals (NES). This shuttling allows TNRC6A to participate in gene silencing in both the nucleus and cytoplasm (Nishi2012Human; Suzawa2017Comprehensive). In the nucleus, TNRC6A colocalizes with miRNAs in nuclear foci, suggesting its involvement in nuclear gene silencing (Nishi2012Human). 

The protein's interaction with the CCR4-NOT complex is modulated by phosphorylation, which acts as a regulatory switch for RNA silencing activities (Munakata2021Identification). TNRC6A also associates with cytoplasmic P-bodies, where it is involved in mRNA regulation and degradation (Li2014TRIM65). Through these interactions, TNRC6A contributes to the regulation of gene expression and maintenance of cellular homeostasis.

## Clinical Significance
Mutations and alterations in the TNRC6A gene have been implicated in various diseases, particularly certain cancers and neurological disorders. In gastric and colorectal cancers, frameshift mutations in TNRC6A are frequently observed, especially in cancers with high microsatellite instability (MSI-H). These mutations often result in reduced or absent TNRC6A expression, which may contribute to cancer development by disrupting microRNA regulation (Kim2010Somatic). The study by Kim et al. found that TNRC6A mutations were present in 52% of gastric cancers and 54% of colorectal cancers with MSI-H, suggesting a significant role in the pathogenesis of these cancers (Kim2010Somatic).

In the context of neurological disorders, a study identified a de novo missense mutation in TNRC6A in a case of sporadic Tourette Syndrome (TS). Although the direct functional association of TNRC6A with TS remains unclear, it is considered a potential candidate gene for further investigation (Eriguchi2017Identification).

Additionally, TNRC6A is involved in microRNA-mediated gene silencing, and its interaction with TRIM65, an E3 ubiquitin ligase, regulates its stability. TRIM65 targets TNRC6A for ubiquitination and degradation, affecting microRNA activity and potentially influencing conditions where miRNA pathways are disrupted (Li2014TRIM65).

## Interactions
TNRC6A, a member of the GW182 protein family, plays a crucial role in RNA silencing by interacting with various proteins and complexes. It serves as a scaffold linking Argonaute (AGO) proteins to the CCR4-NOT complex, which is involved in mRNA degradation. This interaction is facilitated by tryptophan residues in TNRC6A, which are necessary for binding to components like CNOT1 and CNOT9 (Munakata2021Identification). Phosphorylation of specific serine residues in TNRC6A's C-terminal region modulates its interaction with the CCR4-NOT complex. Phosphorylation at S1332 and S1346 enhances interaction with CNOT1, CNOT9, and poly(A)-binding protein (PABP), while phosphorylation at S1616 and S1691 suppresses these interactions (Munakata2021Identification).

TNRC6A also interacts with GIGYF proteins through its conserved PPGL motif, which is crucial for translational repression. This interaction is mediated by the GYF domains of GIGYF1 and GIGYF2, which recognize proline-rich sequences in TNRC6A (Sobti2023Molecular). Additionally, TNRC6A associates with proteins involved in RNA degradation pathways, such as DDX6, TOB, and EDC4, indicating its role in both nuclear and cytoplasmic RNA silencing processes (Suzawa2017Comprehensive).


## References


[1. (Sobti2023Molecular) Meghna Sobti, Benjamin J. Mead, Alastair G. Stewart, Cátia Igreja, and Mary Christie. Molecular basis for gigyf–tnrc6 complex assembly. RNA, 29(6):724–734, February 2023. URL: http://dx.doi.org/10.1261/rna.079596.123, doi:10.1261/rna.079596.123. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.079596.123)

[2. (Li2014TRIM65) Shitao Li, Lingyan Wang, Bishi Fu, Michael A. Berman, Alos Diallo, and Martin E. Dorf. Trim65 regulates microrna activity by ubiquitination of tnrc6. Proceedings of the National Academy of Sciences, 111(19):6970–6975, April 2014. URL: http://dx.doi.org/10.1073/pnas.1322545111, doi:10.1073/pnas.1322545111. This article has 61 citations.](https://doi.org/10.1073/pnas.1322545111)

[3. (Eriguchi2017Identification) Yosuke Eriguchi, Hitoshi Kuwabara, Aya Inai, Yuki Kawakubo, Fumichika Nishimura, Chihiro Kakiuchi, Mamoru Tochigi, Jun Ohashi, Naoto Aoki, Kayoko Kato, Hiroyuki Ishiura, Jun Mitsui, Shoji Tsuji, Koichiro Doi, Jun Yoshimura, Shinichi Morishita, Takafumi Shimada, Masaomi Furukawa, Tadashi Umekage, Tsukasa Sasaki, Kiyoto Kasai, and Yukiko KanoMD, PhD1. Identification of candidate genes involved in the etiology of sporadic tourette syndrome by exome sequencing. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 174(7):712–723, June 2017. URL: http://dx.doi.org/10.1002/ajmg.b.32559, doi:10.1002/ajmg.b.32559. This article has 15 citations.](https://doi.org/10.1002/ajmg.b.32559)

[4. (Chaston2017Structural) Jessica J. Chaston, Alastair Gordon Stewart, and Mary Christie. Structural characterisation of tnrc6a nuclear localisation signal in complex with importin-alpha. PLOS ONE, 12(8):e0183587, August 2017. URL: http://dx.doi.org/10.1371/journal.pone.0183587, doi:10.1371/journal.pone.0183587. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0183587)

[5. (Nishi2012Human) Kenji Nishi, Ai Nishi, Tatsuya Nagasawa, and Kumiko Ui-Tei. Human tnrc6a is an argonaute-navigator protein for microrna-mediated gene silencing in the nucleus. RNA, 19(1):17–35, November 2012. URL: http://dx.doi.org/10.1261/rna.034769.112, doi:10.1261/rna.034769.112. This article has 148 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.034769.112)

[6. (Kim2010Somatic) Min S Kim, Ji E Oh, Yoo R Kim, Sang W Park, Mi R Kang, Sung S Kim, Chang H Ahn, Nam J Yoo, and Sug H Lee. Somatic mutations and losses of expression of microrna regulation‐related genes ago2 and tnrc6a in gastric and colorectal cancers. The Journal of Pathology, 221(2):139–146, May 2010. URL: http://dx.doi.org/10.1002/path.2683, doi:10.1002/path.2683. This article has 92 citations.](https://doi.org/10.1002/path.2683)

[7. (Munakata2021Identification) Fusako Munakata, Masataka Suzawa, and Kumiko Ui-Tei. Identification of phosphorylated amino acids in human tnrc6a c-terminal region and their effects on the interaction with the ccr4-not complex. Genes, 12(2):271, February 2021. URL: http://dx.doi.org/10.3390/genes12020271, doi:10.3390/genes12020271. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes12020271)

[8. (Suzawa2017Comprehensive) Masataka Suzawa, Kentaro Noguchi, Kenji Nishi, Hiroko Kozuka-Hata, Masaaki Oyama, and Kumiko Ui-Tei. Comprehensive identification of nuclear and cytoplasmic tnrc6a-associating proteins. Journal of Molecular Biology, 429(21):3319–3333, October 2017. URL: http://dx.doi.org/10.1016/j.jmb.2017.04.017, doi:10.1016/j.jmb.2017.04.017. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2017.04.017)